Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study [Phase 2]

View source ↗

Summary

This clinical trial is Phase 2 evaluating platelet-rich plasma (PRP) combined with Botulinum toxin type A injections for androgenetic alopecia, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)
  • Platelet-rich plasma (PRP)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Androgenetic Alopecia (AGA) | Phase 2 | Status: RECRUITING